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Diabetes is a leading cause of hospitalization and readmission in the United States. The 
30-day readmission rate for diabetic patients represents substantial costs to the nation’s 
health care system. The purpose of this quantitative study was to examine the relationship 
between primary payer status and hospital readmission rates among individuals whose 
primary or secondary reason for admission was Type 2 diabetes mellitus (T2DM). 
Secondary data from the Healthcare Cost Utilization Program Nationwide Database of 
the 2015 National Readmission Database was analyzed. Participants in the data set 
included 41,068 diabetes patients, 53.8% of whom were female. The average age was 
67.26, and the majority had diabetes with complications (62.1%). The Donabedian 
framework was applied for the analysis. Results of logistic regression analysis showed 
that possession of Medicare and lack of insurance were significant predictors of being 
readmitted within 30 days. Women had higher odds of being readmitted within 30 days 
compared to men. There was no statistically significant relationship between primary 
payer status and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM. Sociodemographic factors such as age, gender, or 
income did not moderate the relationship between primary payer status and 30-day 
hospital readmission rates nationally. The study contributes to positive social change by 
providing hospital administrators with knowledge they can use to implement protocols 
prior to discharge that may prevent possible readmissions, potentially reducing costs to 
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Section 1: Foundation of the Study and Literature Review 
Introduction 
Hospital readmission within 30 days of discharge is a significant aspect of health 
care reform in the United States. The focus of healthcare systems and governmental 
agencies is to identify ways to improve the quality of healthcare, with a special 
concentration on reducing 30-day readmission rates (Ostlling et al., 2017). Reducing 
readmissions gives hospitals a financial incentive to make discharge communication and 
care coordination efforts seamless for patients and caregivers (VanLare & Conway, 
2012). 
Thirty-day readmissions have become an important measure of quality care and a 
target for reducing healthcare costs (Rubin, McDonnell, Golden, & Zhao, 2017). 
Following implementation of the Patient Protection and Affordable Care Act of 2010, the 
Centers for Medicare and Medicaid Services (CMS) began the Hospital Readmission 
Reduction Program (HRRP; Ostlling et al., 2017). The HRRP is composed of five 
specific measures to determine reimbursement rates for hospital readmissions; these 
measures include pneumonia, heart failure, chronic obstructive pulmonary disease 
exacerbation (COPD), acute myocardial infarction, and total hip/knee replacement 
(Ostlling et al., 2017).   
A facility’s 30-day readmission rate is based on all unplanned readmissions that 
occur within 30 days of discharge, regardless of the cause. The risk index includes 
patients who are readmitted to the same hospital or another acute care hospital for any 
reason, regardless of their primary diagnosis. The measures do not include planned 
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 readmissions. Currently, CMS measures hospital performance in the HRRP by 
calculating excess readmission ratios (ERRs) for each of the program measures. A 
hospital’s ERR is the ratio of predicted-to-expected readmissions for a given measure 
(CMS, 2017). Hospitals with high ERRs are subject to a financial penalty; in 2015 alone, 
more than 2,600 U.S. hospitals received reimbursement reductions from CMS because of 
high readmission ratios (Chakraborty et al., 2017). Accordingly, 30-day readmission rates 
have become an important metric for care quality in hospitals in the United States 
(Chakraborty et al., 2017), as well as a focus of hospital administrators charged with 
improving the financial viability of acute care facilities. 
Diabetes is a leading cause of hospitalization and readmission in the United States  
(Donze, Lipsitz, Bates, & Schnipper, 2013), and it creates significant burdens to patients, 
healthcare providers, and the economy (McCoy et al., 2017). This disease affects an 
estimated 23.6 million Americans and is the seventh leading cause of death in the United 
States (Kim, Ross, Melkus, Zhao, & Boockvar, 2010). The prevalence of diabetes 
increases each year (Hicks et al., 2016). An estimated 9.3% of the United States’ 
population was diabetic in 2012 (Centers for Disease Control and Prevention, 2017). 
Experts estimated that 28% of individuals with diabetes are undiagnosed (Ostlling et al., 
2017). The estimated direct costs spent on diabetes in 2012 were $176 billion dollars; 
healthcare costs for individuals with diabetes were 2.3 times higher than for those without 
the disease (American Diabetes Association [ADA], 2013; Kim et al., 2010). Hospital 
care accounts for over half of the healthcare expenditures associated with diabetes (ADA, 
2008).   
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Diabetic patients are susceptible to a host of comorbidities such as congestive 
heart failure (McCoy et al., 2017), neuropathy, retinopathy, stroke, and nephropathy 
(Fowler, 2008). The high incidence of comorbidities associated with diabetes contributes 
to a high 30-day readmission rate among these patients (Ostlling et al., 2017; Raval et al., 
2015), which some studies indicate was as high as 22.7% (Burke & Coleman, 2013; 
Jiang, Stryer, Friedman, & Andrews, 2003; Robbins & Webb, 2006). The costs 
associated with 30-day readmissions among diabetic patients are substantial; the 
Medicare Payment Advisory Commission (MedPAC) estimated that 30-day readmissions 
accounted for annual care spending of $15 billion dollars (Raval et al., 2015). A large 
portion of those costs may also be preventable. Kim et al. (2010) reported that nearly one 
fifth of readmissions could have been prevented, which would have resulted in healthcare 
savings of $72.7 million dollars. 
 A number of other factors also contribute to high readmission rates among 
diabetic patients such as longer length of stay (McCoy et al., 2017), male sex (Robbins & 
Webb, 2006; Rubin et al., 2017; Zapatero et al., 2014), minority race (Basu, Hanchate, & 
Bierman, 2018; Kim et al., 2010; Robbins & Webb, 2006), and low socioeconomic status 
(Kim et al., 2010). Another important predictor of 30-day readmission is insurance status, 
which includes being uninsured or having Medicaid, Medicare, or private insurance 
(Friedman, Jiang, & Elixhauser, 2008; Robbins & Webb, 2006; Rubin et al., 2017). For 
example, Rubin et al. (2017) found that diabetic patients with Medicare and Medicaid 
were significantly more likely to experience a 30-day readmission than were patients with 
private insurance or those who were uninsured. Similarly, Robbins and Webb (2006) 
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found that the likelihood of readmission among diabetic patients with private insurance or 
no insurance was 34.5% and 32.2% lower, respectively, than that of diabetic Medicare 
patients. Kim et al. (2010) also found that patients with Medicare or Medicaid were more 
likely to experience readmission than patients with private insurance.  
A more general study on readmissions conducted by Basu et al. (2018) revealed 
that uninsured patients had the lowest readmission rates of all payer groups and that 
publicly insured patients were the most likely to experience readmission. Among the 
publicly insured, Basu et al. found that Medicare patients were more likely to experience 
readmission than were patients with Medicaid. Findings from Chakraborty’s (2017) study 
echoed those from Basu et al. regarding the high readmission rates among Medicare 
patients across all payer groups. 
Robbins and Webb (2006) posited that higher rates of readmission among 
Medicare and Medicaid patients relative to those with private insurance are reflective of 
socioeconomic factors associated with insurance status. Basu et al. (2018) pointed to 
research that indicated insurance status is associated with aspects of postacute care, 
which correlates with readmission rates. For example, those without insurance may lack 
access to follow-up care, and care decisions for patients with public insurance are often 
driven by financial incentives (Cai, Miller, Nelson, & Mukamel, 2015). Other researchers 
have reported similar trends regarding the influence of insurance status on care outcomes 
(Englum et al., 2016). Basu et al. posited that the phenomenon was the result of the lack 
of insurance coverage and poor access to care, particularly among minorities. Lower rates 
of readmission cannot always be assumed to be a positive indicator of care outcomes 
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(Basu et al., 2018). In addition, the influence of insurance payer status on readmissions 
among diabetic patients is not quite clear as few researchers have examined this issue 
across all payer status types. 
 Applying general interventions across patient populations is cost-prohibitive; 
thus, it is important to identify patients at the greatest risk of 30-day readmission in order 
to more efficiently utilize care resources (Rubin et al., 2017). Insurance payer status is 
likely to be a risk factor, although methodological limitations have made findings from 
previous research somewhat conflicting. Readmission rates may be the result of 
differences in patient characteristics (Basu et al., 2018; Carey & Lin, 2015; Singh, Lin, 
Kuo, Nattinger, & Goodwin, 2014). That is, patients’ demographic characteristics may 
moderate the relationships between insurance payer status and readmission rates.   
This study was unique because it involved an examination of the relationship 
between four insurance payer statuses (Medicare, Medicaid, private insurance, and 
uninsured) and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was Type 2 diabetes mellitus (T2DM). A significant proportion of 
the immense costs associated with diabetes care are attributed to hospitalization and 
readmissions (ADA, 2008; Raval et al., 2015). Much of the existing research on 30-day 
readmission of diabetic patients focuses on Medicare (Chakraborty et al., 2017). The 
findings of this study may inform health care policy makers and healthcare providers 
regarding the readmission rates grouped by diabetic subpopulations at the greatest risk for 
readmission. The potential clarification provided by the study is important because 
interventions aimed at reducing the 30-day readmission rates of diabetic patients are 
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resource intensive (Hansen, Young, Hinami, Leung, & Williams, 2011; Rubin et al., 
2017).  
In this section, I will provide an introduction to the study along with background 
information required to conceptualize the research and expose the gap that was addressed 
in this study. The problem, purpose, research questions and hypotheses, and conceptual 
framework will be presented, followed by discussion of the study’s nature and a review 
of relevant literature. Key terms, assumptions, and delimitations will also be presented. 
The section closes with discussion of the study’s social significance, a summary and 
conclusion, and a transition to Section 2. 
Problem Statement 
Approximately 30.3 million people in the United States have diabetes mellitus 
(DM), which is a modern epidemic (Centers for Disease Control and Prevention [CDC], 
2017). In 2015, diabetes was the seventh leading cause of death in the United States 
(CDC, 2017). Of all patients who are hospitalized or readmitted, 25% were noted as 
having diabetes or an associated comorbidity (Zakowski, 2017). Patients with DM have 
higher acute care hospital readmission rates than non-DM patients (Drincic, Pfeffer, Luo, 
& Goldner, 2017). Diabetic patients have more underlying comorbidities than patients 
without the disease including hypertension, renal failure, diabetic neuropathy, and 
diabetic retinopathy (Moses, Mawby, & Phillips, 2013). These comorbidities may result 
in increased health care spending, elevated hospital readmission rates, and reduced 
quality of life (Schram et al., 2014).  
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According to MedPac, approximately 20% of Medicare patients who are 
discharged from hospitals are readmitted within 30 days (Mcllvennan, Eapen, & Allen, 
2015). Hospital readmissions have become a dangerous and regular occurrence, placing 
an enormous monetary burden on the United States’ health care system (Stefan et al., 
2012.). Reducing preventable readmissions by just 10% could reduce Medicare 
expenditures by $1 billion dollars annually (Raval et al., 2015). More than half of 
hospital readmissions are preventable (Miller & Washington, 2012), including those for 
diabetic patients. In order to prevent readmissions among diabetic patients most employ 
targeted interventions must be employed among patient subpopulations at the greatest 
risk for readmission. A known predictor of readmission is insurance status (Rubin, 
McDonnell, Golden, & Zhoa, 2017); however, a gap in the literature exists regarding 
differences in 30-day readmission rates across different insurance payer groups for 
individuals whose primary or secondary cause for remission is T2DM. According to my 
research, little is known regarding whether and how sociodemographic factors, such as 
race, education level, or marital status, moderate the relationship between insurance 
primary payer status and readmission rates among individuals whose primary or 
secondary reason for readmission is T2DM.   
More research is needed to better understand the factors that place diabetic 
patients at the greatest risk for readmission. Insurance status may affect rates of 30-day 
readmission, for diabetic patients (Friedman et al., 2008; Robbins & Webb, 2006; Rubin 
et al., 2017), yet much of the existing literature focused on Medicare recipients or 
includes all payer groups together (Chakraborty et al., 2017). Jiang et al. (2005) argued 
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that examining 30-day readmission rates across individual payer groups may be useful for 
identifying and targeting interventions for the diabetic subpopulations at the greatest risk 
for readmission.  
Purpose of the Study 
The purpose of this quantitative, correlational study was to use secondary data to 
examine the relationship between primary payer status (Medicare, Medicaid, uninsured, 
or private insurance) and hospital readmission rates among individuals whose primary or 
secondary reason for admission was T2DM. In addition, I analyzed whether 
sociodemographic factors (age, gender, and income) moderate the relationship between 
primary payer status (Medicare, Medicaid, uninsured, or private insurance) and hospital 
readmission rates among individuals whose primary or secondary reason for admission 
was T2DM. Four independent variables (Medicare, Medicaid, uninsured, or private 
insurance) were included in the primary payer status. The dependent variable was 
hospital readmission rate. Three additional variables (age, gender, and income) were 
tested for moderation. I gathered data from the 2015 Healthcare Cost and Utilization 
Project (HCUP) Nationwide Readmission Database (NRD). The scope of the study was 
the United States as a nation, where 9.4% of the population has diabetes, and several 
hundred thousand others are prediabetic (Centers for Disease Control and Prevention, 
2017). Findings from the study may inform health care providers about a possible 
correlation between DM patients’ rate of readmission and insurance payer status. 
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Research Question and Hypotheses 
 Following are the research questions (RQs) and hypotheses for the study. The 
RQs are also illustrated in Figures 1 and 2. 
RQ1. What is the relationship, if any, between primary payer status (Medicare, 
Medicaid, uninsured, or private insurance) and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally? 
Figure 1 illustrates RQ1. 
H01. No statistically significant relationship exists between primary payer status 
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates 
among individuals whose primary or secondary reason for admission was T2DM 
nationally.  
HA1. A statistically significant relationship exists between primary payer status 
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates 





Figure 1. Model for Research Question 1. 
 
RQ2. Do sociodemographic factors like age, gender, and income moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally? Figure 2 illustrates RQ2. 
H02. Sociodemographic factors like age, gender, and income do not moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and hospital 30-day rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
 HA2. Sociodemographic factors like age, gender, and income moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and 30-day readmission rates among individuals whose primary or secondary 
















Figure 2. Model for Research Question 2. 
 
Conceptual Framework 
The conceptual framework of the study was the Donabedian framework, which is 
a conceptual model for examining health services and evaluating the quality of healthcare 
(Sund, Iwarsson, & Brandt, 2015). This framework was developed by Avedis 
Donabedian, a professor at the University of Michigan School of Public Health and one 
of the leaders commissioned to review the quality of public health following enactment 
of the Medicare and Medicaid programs in 1965 (Ayanian & Markel, 2016). The 
Donabedian framework uses information from three categories to determine the quality 
of care including structure, process, and outcome. Structure refers to the method by 


















hospital’s facility, qualifications of care providers, human resources, accounting, and 
material resources (Sund et al., 2015). Process entails the transactions between patients 
and providers during the delivery of healthcare, and it includes the components of care 
delivered to patients (Ayanian & Markel, 2016). Outcome describes the effect of 
healthcare on the health status of patients and populations such as recovery, survival, and 
restoration of health (Ayanian & Markel, 2016; Sund et al., 2015).  
The Donabedian framework provided an important foundation for examining the 
relationships between insurance primary payer’s status, demographic characteristics, and 
30-day readmission rates among patients with T2DM. In the context of this investigation, 
factors related to Donabedian’s definitions of structure and outcomes were examined. 
Insurance coverage and payer status are structural factors, while 30-day readmission rates 
are outcomes. Hyder et al. (2013) used the framework to discuss hospital, physician, and 
patient-level factors that influenced 30-day readmissions among pancreatoduodenectomy 
patients. Moore, Lavoie, Bourgeois, and Lapointe (2015) employed the framework to 
examine trauma care outcomes including readmissions. McHugh and Ma (2013) used 
Donabedian’s framework to explore 30-day readmissions among Medicare patients with 
pneumonia, heart failure, and acute myocardial infarction. In diabetes research, Miles 
(2019) used the framework to assess diabetics’ knowledge of care management as a 
strategy to improve care transition and reduce readmissions. 
Nature of the Study 
 The nature of the study was quantitative, and it followed a cross-sectional, 
correlational design. The population of focus consisted of patients who experienced 30-
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day readmissions to hospitals nationally in 2013 to 2015 for a primary or secondary 
reason of T2DM. The researcher conducted multiple linear regression to assess for a 
correlation between the independent variables of primary payer status (Medicare, 
Medicaid, uninsured, or private insurance) and the dependent variable of hospital 
readmission rate.  
Although some researchers combine Medicaid and Medicare recipients, or 
Medicaid and uninsured patients, Robbins and Webb (2006) cautioned that this exercise 
ought to be evaded except if the two groups are found to have comparative dangers in the 
data. The majority of literature on hospital readmission rates is based on Medicare data; 
much less is known about differences in readmission risks across insurance payer groups 
(Chakraborty et al., 2017). Accordingly, the study involved an examination of each of 
these groups separately. Payer status is an indicator of a patient’s socioeconomic status 
and an impression of the extraordinary segment and clinical attributes of every 
subpopulation (Jiang et al., 2005). In addition, each payer has unique financing 
mechanisms, provider networks, and models of delivery (Jiang et al., 2005), so it is 
important to examine payer status, separately. By examining 30-day readmission rates 
associated with each payer status, and understanding how demographic characteristics 
may moderate these relationships, policymakers and healthcare providers may use 
findings to more efficiently target subpopulations at risk for readmission (Jiang et al., 
2005). 
For the second RQ, demographic characteristics, age, gender, and income were 
examined as potential moderators in the relationships between primary insurance payer 
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status and hospital readmission rates. A multivariable analysis allowed the researcher to 
examine the relationships between the dependent and independent variables. Findings 
may shed light on differences in readmission rates among T2DM patients based on 
primary payer status, and how patient characteristics may moderate those relationships.  
Literature Review 
 This section includes a review of the existing research on diabetes, hospital 
readmissions, and the influence of insurance coverage on care outcomes such as 
readmission rates. Topics in this review include 30-day readmission rates in United 
States’ hospitals, Medicare history, incidence of diabetes in the United States, costs of 
diabetes, diabetes and 30-day readmission rates, Medicare spending on diabetes, 
readmission risk index for diabetic patients, socioeconomic status and readmission, 
insurance coverage and 30-day readmission rates, and care discrepancies by insurance 
status.   
Literature Search Strategy 
The intention of the research study was to examine the relationship between 
insurance primary payer status (Medicare, Medicaid, uninsured, or private insurance) and 
hospital readmission rates among individuals whose primary or secondary reason for 
admission was T2DM. In addition, the researcher examined if sociodemographic factors 
(age, gender, income) moderate the relationship between insurance primary payer status 
and hospital readmission rates among these patients. In order to contextualize the study 
and provide adequate background information, an exhaustive review of the literature was 
performed. Relevant peer-reviewed sources were gathered from a number of online 
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databases, including Medline, EBSCOhost, government reports, Cochrane, PubMed, 
BioMed Central, Google Scholar, and Cumulative Index to Nursing and Allied Health 
Literature (CINAHL). Additional relevant resources included databases provided by the 
Centers for Medicare & Medicaid (CMS) and the National Institute of Health (NIH). The 
researcher endeavored to include recent scholarship published within the last 5 years. 
Older studies that were relevant or seminal were included as appropriate. Table 1 
provides a summary of search terms employed, the number of corresponding results, and 
the total resources used for each.  
Table 1 
Summary of Literature Review Keywords/ Boolean Phrase Search Terms 
Keyword/Boolean phrase Google Scholar search engine 
results 
Resources 
Affordable Care Act and 30 readmission 
rate 
18,000 4 
Medicare spending on diabetes 17,000 12 
Medicare spending in the state of Georgia 
on diabetes 
14,100 7 
30-day readmission rate for Medicare 
diabetic patients 
16,100 12 
30-day readmission rate and Medicare 
spending for diabetic patients 
17,800 12 
ICD 10 code for diabetes 19,200 3 
How is Medicare funded 24,500 4 
CMS and diabetes 21,800 2 




A matrix of the selected literature is provided in Appendix. This matrix highlights 
the following characteristics of each study: authors, population, variables, study type, and 
outcomes. Overall, findings from the matrix revealed the gap in research regarding the 
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ways primary payer status and sociodemographic factors may influence readmission rates 
among individuals with T2DM. This literature review expands on the information 
included in the matrix by revealing the research gap and contextualizing the study. 
30-Day Readmission Rates in United States’ Hospitals 
Thirty-day readmissions have become an important measure of care quality and 
target for reducing healthcare costs (Rubin et al., 2017). Following implementation of the 
Affordable Care Act, the Center for Medicare and Medicaid Services (CMS) began 
utilizing a Hospital Readmission Reduction Program (HRRP), which was part of the 
Patient Protection and Affordable Care Act (Ostlling et al., 2017). The HRRP is 
composed of five specific measures to determine reimbursement rates for hospital 
readmissions which include pneumonia, heart failure, chronic obstructive pulmonary 
disease exacerbation (COPD), acute myocardial infarction, and total hip/knee 
replacement (Ostlling et al., 2017).   
The 30-day readmission measures include all unplanned readmissions that occur 
within 30 days of discharge, regardless of the cause. The risk index includes patients who 
are readmitted to the same hospital or another acute care hospital for any reason, 
regardless of their primary diagnosis. The measures do not include planned readmissions. 
Currently, CMS measures hospital performance in the HRRP by calculating excess 
readmission ratios (ERR) for each of the program measures. A hospital’s ERR is the ratio 
of predicted-to-expected readmissions for a given measure (Centers for Medicare and 
Medicaid Services, 2017). Hospitals with high ERRs are subject to financial penalty; in 
2015, more than 2,600 hospitals received reimbursement reductions from CMS because 
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of high readmission ratios (Chakraborty et al., 2017). Accordingly, 30-day readmission 
rates have become an important metric for care quality in United States’ hospitals 
(Chakraborty et al., 2017), as well as a focus of leaders charged with improving the 
financial viability of acute care facilities. Many local, state, and national campaigns have 
emerged to help reduce readmission rates (Bradley et al., 2013). 
Despite increase attention to the issues of readmission, evidence regarding the 
best strategies for reducing readmissions is still limited (Bradley et al., 2013). In 
controlled trials, readmission interventions focus on follow-up and nurse staffing 
demonstrated success (Coleman, Parry, Chalmers, & Min, 2006). Bradley et al. (2013) 
pointed out less is known about the effectiveness of such interventions outside of 
controlled trials. Large variation exists in the strategies used by hospitals to reduce 
readmission (Bradley et al., 2012; House, Stephens, Whiteman, Biearman, & Printz, 
2016). 
Medicare History 
The topic of 30-day readmission has received growing attention since CMS began 
to penalize acute care facilities that demonstrate high rates of readmission among 
Medicare and Medicaid patients by reducing reimbursements. Medicare is a federal 
health insurance program that was formed in 1965 by President Lyndon B. Johnson 
(Tierney, 2013). The Medicare Program is the second-largest social insurance program in 
the United States (CMS, 2013). The initial purpose of the Medicare program was to 
provide medical insurance to individuals who were 65 years of age or older (Oberlander, 
2019). In 1972, President Nixon expanded the Medicare program to include individuals 
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with end-stage renal disease and acute disabilities (Tierney, 2013). Medicare spending is 
mainly controlled and regulated by the federal government (McHugh & Ma, 2013). 
Medicare is paid through the Hospital Insurance Trust Fund (HI) and the Supplemental 
Insurance Trust (Tierney, 2013).  
The HI trust is funded through payroll taxes, income taxes, and Medicare Part A 
premiums (Tierney, 2013). These HI funds are managed by a board of trustees that 
provides annual reports to Congress on the financial status of the plan. The soundness of 
the HI trust fund is one of the measurements of Medicare’s financial status (Davis et al., 
2017). Since the sole concentration of the HI trust fund is the status of Medicare Part A, it 
does not portray a thorough analysis of the program expenditures (Davis et al., 2017). 
During years when annual income to the trust fund exceeds benefits spending, the asset 
level increases; when yearly spending exceeds revenues, the asset level decreases (Davis, 
et al., 2017). Although the HI trust fund was expected to become insolvent, government 
regulations and changes have sustained it. The latest legislative changes suggest the HI 
trust fund will become bankrupt by the year 2026, barring any further governmental 
regulations (Davis et al., 2017). 
The Supplemental Insurance Trust Fund, which includes Medicare Part B and Part 
D, is funded through premiums of Medicare recipients (Davis et al., 2017). Part B covers 
outpatient services, home health, and preventive care services (Davis et al., 2017). Part D 
offers voluntary Medicare prescription drug benefits for recipients through private 
insurance plans (Shrank & Polinski, 2015). When Medicare Part D was implemented in 
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2006, it was the most significant expansion to Medicare since its inception in 1965 
(Shrank & Polinski, 2015).   
The number of individuals enrolled in Medicare is substantial. It was reported that 
in 2013, there were over 40 million beneficiaries in the United States and by 2030 this 
number will increase to about 84 million (MedPAC, 2017). As the baby boomer 
generation ages out of the workforce, the burden to support Medicare will rise as 
contributors decrease. According to MedPAC (MedPAC, 2017), “the number of 
taxpaying workers per Medicare beneficiary has declined form 4.6 during the early years 
of the program to 3; by 2029, this number is projected by the Medicare Trustees to be 
2.4” (p. 16). These figures help to illustrate how increasingly burdened the Medicare 
program will continue to become, and why the costs of hospital readmissions receive 
growing attention from leaders and policymakers. 
Prevalence of Diabetes in the United States 
A major contributor to the readmission rate among individuals with Medicare and 
Medicaid is diabetes (Rubin et al., 2017). Diabetes affects an estimated 23.6 million 
Americans, and it is the seventh leading cause of death (Kim et al., 2010). The prevalence 
of the disease is steadily rising (Hicks et al., 2016). Ostlling et al. (2017), and it has been 
estimated that 9.3% of the United States’ population is diabetic, 28% of which is 
undiagnosed. A comprehensive estimate of the prevalence of diabetes in the United 
States conducted by Menke, Casagrande, Geiss, and Cowie, (2015) revealed the 
prevalence rate was even higher. Using cross-sectional survey data, Menke et al. (2015) 
reported that the unadjusted prevalence of diabetes was 14.3% with over 25% of those 
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cases undiagnosed. The rate of the disease is higher among non-Hispanic Blacks (21.8%), 
non-Hispanic Asians (20.6%), and Hispanics (22.6%) (Menke et al., 2015).  
The increasing prevalence of diabetes aligns well with the increasing prevalence 
of obesity among the United States’ population (Menke et al., 2014). As explained by the 
NCD Risk Factor Collaboration (2015), the incidences of diabetes and diabetes-related 
mortality have increased throughout the world, largely fueled by global increases in being 
overweight and obese. The upward trend in diabetes created significant consequences for 
individuals and health care systems (Zimmet, Magliano, Herman, & Shaw, 2014). The 
prevalence of T2DM is highest among the elderly, minorities (non-Hispanic American 
Indian, non-Hispanic Blacks, and Hispanics), and slightly more common in men than 
women (Bullard et al., 2018). 
Cost of Diabetes 
The costs of the increasing prevalence of diabetes in the United States are 
substantial. The estimated direct costs spent on diabetes in 2012 were $176 billion dollars 
(ADA, 2013); healthcare costs for individuals with diabetes are 2.3 times higher than for 
those without the disease (Kim et al., 2010). Hospital care accounts for over half of the 
healthcare expenditures associated with diabetes (ADA, 2008), which are not just related 
to enormous healthcare expenses, but also the loss of productivity among those sick with 
the disease. Menke et al. (2015) estimated the total costs in care and lost productivity 
associated with diabetes to be $245 billion dollars annually, while Bullard et al. (2018) 
estimated total costs of diabetes to be $327 billion dollars.  
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Diabetes and 30-Day Readmission Rates 
A large proportion of the healthcare costs associated with diabetes is attributed to 
hospital readmissions. Diabetic patients are susceptible to a host of comorbidities such as 
congestive heart failure (McCoy et al., 2017), neuropathy, retinopathy, stroke, and 
nephropathy (Fowler, 2011). Co-morbidities associated with diabetes correlate to the 
22.7% 30-day readmission rate among these patients at a substantial cost (Burke & 
Coleman, 2013; Ostlling et al., 2017; Raval et al., 2015). The 30-day all-cause 
readmission rate is 13.9% (Fingar, Barrett, & Jiang, 2017), indicating that readmission 
rates specific to diabetes are significantly higher. Robbins and Webb (2006), in a 
germinal study, found that when diabetes was a primary diagnosis, the 30-day 
readmission rate was 9.4% but if a diabetic patient was admitted for another reason and 
diabetes was not listed as a secondary diagnosis, the 30-day readmission rate was 30.6%. 
For example, Medpac estimated that all-cause 30-day readmissions accounted for annual 
care spending of $15 billion dollars (Raval et al., 2015). Kim et al. (2010) estimated that 
nearly one-fifth of readmissions may have been prevented, which would have resulted in 
healthcare savings of $72.7 million dollars. The potential for reducing readmissions is of 
interest to policymakers and healthcare leaders and is a target of the study.  
Insurance Coverage and 30-Day Readmission Rates  
In addition to high rates of comorbidities, several research studies indicate that a 
number of other factors contribute the high readmission risk among diabetic patients. 
These factors include hospital length of stay, male gender, minority race, and low 
socioeconomic status (Basu et al., 2018; Kim et al., 2010; McCoy et al., 2017; Rubin et 
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al., 2017; Zapatero et al., 2014). An important predictor of 30-day readmissions may be 
insurance status and type, Medicaid, Medicare, private insurance, or uninsured (Friedman 
et al., 2008; Robbins & Webb, 2006; Rubin et al., 2017). Rubin et al. (2017) found that 
diabetic patients with Medicare and Medicaid were more likely to experience a 30-day 
readmission than patients with private insurance or those who were uninsured. Rubin et 
al. reported 30-day readmission rates for Medicare and Medicaid recipients were 45.6% 
and 11.6%, respectively. Everett and Mathioudakis (2019) found that insurance status 
was the strongest predictor of readmission among diabetic ketoacidosis patients.  
In a study of socioeconomic, clinical, and demographic factors associated with 
readmissions among diabetic patients, Kim et al. (2010) found that patients with 
Medicare or Medicaid were more likely to experience readmission than patients with 
private insurance. Hicks et al.’s (2016) study on the costs of foot ulcers among diabetic 
patients revealed that over three-quarters of hospitalized patients had Medicare or 
Medicaid. A more general study on readmissions conducted by Basu et al. (2018) 
revealed that uninsured patients had the lowest readmission rates of all payer groups, and 
publicly insured patients were the most likely to experience readmission. Among the 
publicly insured, Basu et al. found that Medicare patients were more likely to experience 
readmission than patients with Medicaid. Findings from Chakraborty’s (2017) study 
echoed those from Basu et al. regarding the highest readmission rates among Medicare 
patients across all payer groups. 
Robbins and Webb (2006) posited that higher rates of rehospitalization among 
Medicare and Medicaid patients relative to those with private insurance is likely to reflect 
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socioeconomic factors associated with insurance status. Basu et al. (2018) indicated 
insurance status is associated with aspects of post-acute care which correlates with 
readmission rates. For example, those without insurance may lack access to follow-up 
care, and care decisions for patients with public insurance are often driven by financial 
incentives (Cai et al., 2015). Other researchers have reported similar trends regarding the 
influence of insurance status on care outcomes (Chakraborty, et al., 2017; Englum, et al., 
2016). For example, Englum et al. (2016) examined the relationship between hospital 
status and length of stay among trauma patients and found that uninsured patients had a 
significantly shorter length of stay than patients with private insurance. Publicly insured 
patients in Englum et al.’s study had the longest length of stay; however, this does not 
necessarily indicate that publicly insured patients received the best care. In fact, 
researchers reported that longer lengths of stay are associated with higher risks for 30-day 
readmission (Chakraborty et al., 2017).   
Medicare Spending on Patients with Diabetes Mellitus 
Medicare spending is estimated to grow to about $171 billion dollars by the year 
2034 (Raval, et al., 2015). Diabetic patients are hospitalized frequently (Raval et al., 
2015). The program currently spends about 32% of its budget on diabetes and associated 
comorbidities (Silveira et al., 2018). According to Erkan Erdem (2014), the average 
annual Medicare spending on diabetes patients with Part A and Part B Medicare is $5,741 
to $5,991 dollars.  
Hospital readmissions are linked to poor patient outcomes and increased monetary 
expenditures (Mcllvennan et al., 2015). Approximately 25% of all hospitalized patients 
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have DM (Ostlling, et al., 2017) The direct medical costs of DM were $176 billion 
dollars in 2012, 43% of which was spent on direct inpatient care (Ostlling et al., 2017). 
Many factors contribute to hospital readmission within 30-days of discharge. For 
example, diabetes care increases the use of health care services, medications, and medical 
supplies (Mcllvennan et al., 2015). Medicare patients comprise almost 20% of 30-day 
hospital readmissions (Mcllvennan et al., 2015). 
Over 21 million medical doctor office visits annually are scheduled for diabetes. 
An estimated one-third of Medicare expenditures are related to diabetes (Dugan & 
Shubrook, 2017). Coding for diabetes must be accurate to ensure that the providers and 
institutions receive the proper reimbursement rate. In accordance with ICD-10 guidelines, 
coding for diabetes requires four or five digits, for accuracy. The coding identifies the 
type of diabetes, patient’s current diabetic status (i.e. Type 1, Type 2, or gestational 
diabetes), and comorbidities of the disease (Dugan & Shubrook, 2017). 
In 2010, under the Affordable Care Act, the federal government instituted two 
programs aimed at reducing 30-day hospital readmissions. These programs included the 
Hospital Readmissions Reduction Program (HRRP) and the Bundled Payments for Care 
Improvement Initiative (BPCI) (Carey & Stefos, 2016). The HRRP is the most developed 
mandatory incentive of the CMS program and has the largest monetary impact on 
hospitals across the country (Ryan, Adler-Milstein, Damberg, Maurer, & Hollingsworth, 
2017). Under the HRRP, CMS reduces payments to inpatient prospective payment 
systems (IPPS) hospitals with excessive readmission rates (Carey & Stefos, 2016). The 
first penalties affecting the payments were for discharges beginning in October, 2012. 
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During the 2013 fiscal year, CMS began imposing a payment reduction of up to 1% to 
hospitals that exceeded expected readmission rates for acute myocardial infarction 
(AMI), heart failure, and pneumonia (Ryan et al., 2017). By the 2015 fiscal year, the 
payment reduction increased to 3% (Ryan et al., 2017).  
The BPCI was an initiative developed by CMS to improve care by bundling 
payments for beneficiaries of multiple services for single care episodes (Andrawis, 
Koenig, & Bozic, 2016).  Under the BPCI, healthcare facilities enter payment agreements 
that stipulate financial and performance accountability for care episodes. The goal of the 
BPCI is to improve care quality and coordination while lowering Medicare costs 
(Andrawis, Koenig, & Bozic, 2016).  
Medicare’s prospective payment system (PPS) was introduced in 1983. Under this 
system, hospitals are paid a fixed rate per admission diagnosis (Krinsky, Ryan, 
Mijanovich, & Blustein, 2017). A primary component of PPS is the diagnosis-related 
groups (DRGs), which consist of medical and surgical services (Bowman, 2016). The 
World Health Organization adopted the International Classification of Disease, ICD-10 
revision in 2004, which is the international standard (Bowman, 2016). The ICD-10 
replaced the ICD-9, which lacked detail expected to precisely reflect current clinical 
phrasing and methods and can't be extended further to remember new revelations and 
methodology for medication (Coutasse & Paul, 2013). The United States did not 
officially mandate the implementation of the ICD-10 until October 2015 (Bowman, 
2016). Although the CMS originally mandated the transition to ICD-10 codes by 2011, 
the transition was twice delayed due to financial and administrative concerns expressed 
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by care providers regarding their ability to comply with the transition deadlines. The 
DRGs categorize all human ailments according to the body part that is affected by the 
illness, the sex of the patient, and morbidity (Bowman, 2016). Eight diagnoses are 
accounted for in the classification and up to six procedures during the hospital stay 
(Bowman, 2016). 
Readmission Rate for Medicare Patients with Diabetes  
 A systematic review by Raval et al. (2015) utilized a nationwide database of 
Medicare recipients to estimate the frequency of 30-day readmission rates among elderly 
Medicare beneficiaries with T2DM. The study followed a retrospective longitudinal 
cohort design. The timeframe of the study was between January 2007 and August 2011. 
The study population consisted of 12 million Humana Medicare Advantage part D 
recipients who (a) had a primary or secondary diagnosis of T2DM; (b) were 65 years of 
age and older; and (c) were enrolled in the plan between January 2007 and April 2012. 
Participants were enrolled in the plan six months before admission and 30 days after 
hospital discharge. The dependent variable of the study was readmission rate. Recipients 
were categorized into two groups: (a) recipients who were re-admitted within 30 days; 
and (b) recipients with no readmission with 30 days.  
 The independent variables in Raval et al.’s (2015) study included length of stay, 
sex, age, secondary diagnosis diabetes, and primary diagnosis diabetes. The results of the 
study were consistent with similar studies on patient 30-day readmission rates for T2DM, 
in which patient-level stressors of overall poor health conditions that are specifically 
related to the elderly population (such as cognitive impairment, falls, and fall risks) were 
27 
 
the most commonly identified risk factors for readmission. These findings may have 
implications for reducing the 30-day hospital readmission rate through effective post-care 
planning before discharge. 
Sonmez, Kambo, Avtanksi, Lutsky, and Poretsky (2017) conducted a 
retrospective cohort study of 102,694 patients who were admitted to an urban teaching 
hospital between January 1, 2013 and September 30, 2015. The primary or secondary 
admitting diagnosis had to be diabetes in order for the patient to be included in the study. 
The number of patients with a primary or secondary admitting diagnosis of diabetes was 
16,266. The researchers compared 30-day hospital readmission rates for patients with 
diabetes to those without the disease. The researchers also examined the connections 
between the length of stay (LOS) for patients with diabetes and the length of stay for 
patients without diabetes. The data source was the hospital billing system. The dependent 
variables were readmission rate with or without diabetes. The independent variables were 
length of stay, gender,  age, secondary diabetes, and primary diabetes.  
The results of Somez et al.’s (2017) study revealed that diabetic patients were 
2.47 times more likely to be readmitted than patients without diabetes. Patients 65 years 
of age and older were more likely to be readmitted within 30 days than patients between 
the ages of 18 and 64. The researchers also found that male diabetic patients were more 
likely to be readmitted than female patients. A major limitation of this study is that it was 
conducted at a single urban hospital, and other area hospitals were not included in the 
study. As a result of the study being retrospective, there may have been bias in the patient 
selection process, data accuracy, and patient follow-up. The data from the hospital billing 
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system did not include clinical information about patients’ medical conditions which may 
have impacted the LOS or readmission rates.  
A cross sectional study conducted by Alavi, Baharlooei, and AdelMehraban 
(2017) revealed that despite the advances in diabetic care and treatment, elderly patients 
still had high rates of hospital readmissions. The primary goal of the study was to 
examine the psychosocial factors that may contribute to the readmission rate of elderly 
diabetic patients. The researchers concluded that developing social support services may 
help in the reduction of readmission rate for this population while also improving the 
mental health status of the elderly. However, the researchers recommended further 
research on ways to decrease depression, anxiety, and stress among the elderly.  
Readmission Risk Index for Diabetic Patients 
The Diabetes Early Readmission Risk Index (DERRITM) is a multivariable 
logistic regression model tool that predicts all-cause 30-day readmission risks for 
patients who are hospitalized with diabetes (Rubin, 2018). Persons with diabetes account 
for about 20% of hospitalizations annually (Rubin et al., 2017). Diabetic patients with 
cardiovascular disease (CVD) comprise 25% to 30% of the hospital admissions for this 
subgroup (Rubin et al., 2017). Rubin et al. (2017) simulated the tool and added 
cardiovascular disease to the tool in a retrospective cohort study. The tool was called the 
Diabetes Early Readmission Risk Indicator for cardiovascular disease (DERRI-CVDTM). 
The aim of the study was to compare the performance of the DERRITM  to the DERRI-
CVDTM. The study consisted of 8,189 discharges between January 1, 2004, and 
December 31, 2012, which were selected from the electronic medical records system of 
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Boston Medical center. The cohort was the same one that was used for the DERRI TM. 
However, the DERRI TM  did not have the stipulation of having a primary diagnosis of 
CVD. The primary purpose of the study was to invent a functional tool that would predict 
the 30-day readmission risk for diabetic patients with CVD (Rubin et al., 2017). 
To be included in Rubin et al.’s (2017) study, the patient’s primary discharge 
diagnosis had to be CVD, which included heart attack, heart disease, stroke, peripheral 
vascular disease, and diabetes. The researchers believed that if the readmission risk of 
this population could be predicted, the patients identified as high risk could be singled out 
which would enable resources to be used more efficiently and effectively. The results of 
the study revealed vast similarities in the predictors of the DERRITM  and the DERRI-
CVDTM.  
The most common shared 30-day readmission predictors in Rubin et al.’s (2017) 
study were diabetes, heart failure, shortness of breath, chest pain, peripheral arterial 
disease, and acute kidney failure. The results of the DERRI-CVDTM  were similar to the 
DERRITM; therefore, either model may be useful for identifying diabetic patients 
admitted with CVD who are at an elevated risk for a 30-day readmission. All these 
predictors are easily gathered at the time of patient admission, health administrators may 
utilize the tool to implement protocols focused on diabetic CVD patients with high risks 
for 30-day readmissions. This tool may help to lower the financial burdens to healthcare 
facilities while improving patient outcomes (Rubin et al., 2017).  
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Socioeconomic Status and Hospital Readmission Rates  
Socioeconomic status is a significant determinant of health among patients with 
diabetes (Assari, Moghani Lankarani, Piette, & Aikens, 2017). Researchers around the 
world have reported that social characteristics, such as low education, low income, 
marital status, and race, are associated with increased risks for diabetes. Likewise, 
comparative trends have been documented for readmission frequency and rate among 
diabetic patients (Assari et al., 2017).  
Assari et al. (2017) conducted a cross-sectional study using a consective sampling 
strategy. The purpose of the study was to evaluate the differences between 
socioeconomic status (SES) and Hemoglobin A1c (HbA1c) levels among Black and 
White patients with T2DM. The researchers found that SES had a greater impact on the 
HbA1c levels of Black males than any other subgroup in the study. Findings also 
revealed that Black males and females developed diabetes at a younger age than White 
males and females. The results of the study may contribute to governmental policy 
reform, but more research is needed among a larger sample (Assari et al., 2017).   
Diabetic ketoacidosis (DKA) is one of many acute complications of Type 1 
diabetes mellitus (T1DM) and a leading cause of death in children and young adults with 
the disease (Everett & Mathioudakis, 2019). Everett and Mathioudakis (2019) conducted 
a cross-sectional study using the National Readmission Database (NRD) to identify 
181,284 T1DM patients admitted for DKA between 2010 and 2015. The purpose of the 
study was to examine patient- and hospital-level predictors of T1DM patients with 
recurrent DKA who were admitted or readmitted with a special focus on patient 
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socioeconomic status. To be included in the study, the admission had to be the first 
admission for the patient within the specific calendar year and the primary diagnosis had 
to be recurrent DKA. Results revealed that participants from the lowest socioeconomic 
income quartile had a 50% chance of four or more hospital readmissions with DKA 
within a single calendar year. The researchers also reported that patients with government 
insurance (i.e., Medicare or Medicaid) were at an increased risk of hospital readmissions 
with DKA, as well as those who went home against the advice of medical professionals. 
The researchers concluded that further investigation was needed to examine the 
relationship between DKA and hospital readmissions among this high-risk subgroup. 
Such research may reveal which types of interventions such as patient education or 
community outreach will help this population (Everett & Mathioudakis, 2019) .  
Across the globe, it is estimated that one person dies from diabetes-related 
complications, every six seconds (Bird, Lemstra, Rogers, & Moraros, 2015). In 2011, the 
Public Health Agency of Canada (PHAC) published a report on diabetes that determined 
the primary adjustable risk factors for diabetes were obesity, lack of physical activity, 
smoking, and unhealthy eating habits. The non-adjustable risks factors included race and 
recent immigration status, but the report did not mention correlations with socioecomonic 
status or income. 
A cross-sectional population-based study conducted by Bird et al., (2015) was 
conducted to determine if a correlation existed between T2DM and socioecomonic/ 
income status in the Canadian province of Saskatchewan. Data collected from the 
Canadian Community Health Survery (CCHS) between 2000 and 2008 were analyzed. 
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The CCHS is a self reporting survey. The sample included 27,090 residents. Four distinct 
and separate models were built, which examined the effect of income on T2DM in 
correlation wih the conditions of hypertension, obesity, and physical activity. Study 
results revealed that socioeconmic status was closely associated with T2DM and its 
underlying comorbidites, such as hypertension and obesity. Internationally, findings from 
this study provide evidence that socioeconomic and income status may relate to increased 
morbidity and mortality (Bird et al., 2015). 
Care Discrepancies by Insurance Status 
Readmission among diabetic patients may also relate to insurance status. Basu et 
al. (2018) indicated insurance status is associated with aspects of post-acute care, which 
correlates with readmission rates. Those without insurance may lack access to follow-up 
care, and care decisions for patients with public insurance are often driven by financial 
incentives (Cai et al., 2015). Other researchers have reported similar trends regarding the 
influence of insurance status on care outcomes. Englum et al. (2016) examined the 
relationship between hospital status and length of stay among trauma patients and found 
that uninsured patients had significantly shorter lengths of stay than patients with private 
insurance. Publicly insured patients in Englum et al.’s study had the longest lengths of 
stay; however, this does not necessarily indicate that publicly insured patients received 
the best care. In fact, many researchers have reported that longer lengths of stay are 
associated with higher risks for 30-day readmission (Chakraborty et al., 2017).  
Discrepancies in resource use among underinsured patients may reflect the shorter 
lengths of stay (Englum et al., 2016), but do not explain the lower rates of readmission 
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among this group. Basu et al. (2018), who also found readmission rates to be lower 
among the underinsured, posited that the phenomenon was the result of the lack of 
insurance coverage and poor access to care – particularly among minorities. Accordingly, 
the researchers cautioned that lower readmission rates may not generally be interpreted as 
a decent result (Basu et al., 2018). 
A substantial body of literature indicates that uninsured patients receive 
inefficient and lower quality care than insured patients; however, less is known about 
differences in the quality of care provided to privately-insured versus publicly-insured 
patients (Englum et al., 2016). Some researchers have reported publicly insured patients 
undergo fewer procedures (Haas & Goldman, 1994; Wenneker, 1990) and have worse 
morbidity (Ayanian et al., 1993; Braveman et al., 1994) than the privately-insured. Other 
researchers have reported incongruence in findings comparing mortality rates among 
publicly and privately insured patients (Englum et al., 2016). 
 To date, interventions aimed at reducing 30-day readmissions among diabetes 
patients have demonstrated inconsistent outcomes (Hansen et al., 2011; Rubin et al., 
2017). Such interventions have focused on improving discharge planning and 
transactional care and providing patients with timely follow-up (Drincic et al., 2017). As 
Rubin et al. (2017) explained, applying general interventions, especially when they only 
demonstrate modest effects, across patient populations is cost-prohibitive. Thus, it is 
important to identify patients at the greatest risk of 30-day readmission in order to more 
efficiently utilize resources. Similarly, Dugan and Shubrook, (2017) suggested that 
targeting interventions to high-risk groups could improve cost-to-benefit ratios. 
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Structured and individualized discharge plans may help reduce 30-day readmission 
among patients at the highest risk (ADA, 2019). As Basu et al. (2018) urged, the role of 
insurance should be examined in order to evaluate efforts to reduce readmissions. In 
addition, because readmission rates may be the result of differences in patient 
characteristics (Basu et al., 2018; Carey & Lin, 2015; Singh et al., 2014), it is also 
important to understand how patients’ demographic characteristics may moderate the 
relationships between insurance payer status and readmission rates.   
Definitions 
Following are definitions of key terms that will be used throughout this study:  
30-day readmission: Rehospitalization that occurs within 30 days of discharge 
from the initial hospitalization (Rubin et al., 2017). 
Centers for Medicaid and Medicare (CMS): A unit within of the Department of 
Health and Human Services (CMS, 2017). 
Diabetes mellitus (DM): A chronic disease caused by an inherited or acquired 
deficiency in production of insulin by the pancreas. Symptoms of the disease include 
excessive urination, elevated blood sugar, and insulin resistance (CMS, 2017). 
Diabetic ketoacidosis (DKA): A serious acute complication of Type 1 diabetes 
caused by a build-up of acid in the blood (Everett & Mathioudakis, 2019).  
Diagnosis-related group (DRG): A statistical method of classifying inpatient 
stays into groups, which assists with insurance compensation (CMS, 2017). 
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Excess readmission ratios (ERRs): A measure of a hospital’s readmission 
performance compared to the national average for hospitalized patients with applicable 
conditions (CMS, 2017). 
Healthcare Cost and Utilization Project (HCUP): A family of health care 
databases and related software tools and products developed through a federal and state 
industry partnership and sponsored by the Agency for Healthcare Research and Quality 
(CMS, 2017). The HCUP databases bring together the data collection efforts of state data 
organizations, hospital associations, private data organizations, and the federal 
government to create a national information resource of encounter-level health care data 
(CMS, 2017). 
Hospital Consumer Assessment of Healthcare Providers and Systems (HCAHPS): 
The first national, standardized, and publicly reported survey of patients’ views of the 
care they receive in hospitals (CMS, 2017). The survey is also known as the CAHPS 
hospital survey. The survey consists of 27 question about patients’ hospital stays, 18 of 
which are related to critical elements of the patient hospital experience (CMS, 2017).  
Hospital Readmissions Reduction Program (HRRP): A pay-for-performance 
program that lowers payments to Inpatient Prospective Payment System (IPPS) hospitals 
that have too many readmissions (Centers for Medicare and Medicaid Services, 2017). 
Medicaid: A state and federally funded program that provides health coverage to 
eligible low-income adults, children, pregnant women, older adults, and people with 
disabilities (CDC, 2017). The program is state-administered in compliance with federal 
requirements (CDC, 2017). 
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Medicare: A single-payer, national social insurance provider governed by the 
United States government (CMS, 2017). 
National Inpatient Sample (NIS): One of the HCUP databases that is the most 
extensive and publicly available all-payer inpatient health care database in the United 
States, yielding national estimates of hospital inpatient stays (CMS, 2017). 
Primary payer status: An indicator of insurance type, categorized by the party 
responsible for payment (Xu et al., 2017). In this study, primary payer status was 
categorized into the following four groups: Medicare, Medicaid, uninsured, and private 
insurance. 
Private insurance: Any type of health insurance that is purchased by an individual 
or obtained through an employer (Delaware Assistive Technology Initiative, n.d.). Unlike 
Medicare and Medicaid, private insurance is not federally funded. 
Race: Groups of people who have differences and similarities in biological traits 
deemed by society to be socially significant (CMS, 2017). 
Readmission: The return of a patient to a healthcare facility after being previously 
discharged for the same illness (CMS, 2017). 
Type 2 diabetes mellitus (T2DM): A form of diabetes in which the pancreas 
produces too little insulin, or the body rejects the insulin that it produces. T2DM can 
usually be controlled with medication, diet, and exercise (Georgia Department of Public 




The first assumption of this study was that the HCUP NRD database would 
contain all the necessary variables for the study for T2DM. Variations may be shown 
depending on the geographical location in which data is derived to demonstrate 
differences in readmission rates and insurance status. It was also assumed that all utilized 
data have been accurately entered into the HCUP NRD database. 
Scope and Delimitations 
 The scope of the study was based on the Healthcare Cost and Utilization Project 
(HCUP) Nationwide Readmission Database (NRD), 2015. This investigation only 
included readmission data for patients who were admitted to hospitals nationally between 
Jan 1, 2015 and Dec 31, 2015. Nationally was selected as the focus of this investigation 
because 9.4% of the population has diabetes (American Health Rankings, 2019).  
This study was also limited by the payer status categories selected. For example, a 
status of private insurance included any type of insurance plan purchased by an 
individual or provided by an employer. Differences across types of private insurance 
were not included. The researcher also selected to examine Medicare and Medicaid 
separately rather than combining them under the category of public insurance, as many 
previous researchers have. Findings may differ if the definition and organization of payer 
status was different. 
 Other delimiting factors included the researcher’s selection of conceptual 
framework and study method and design. The demographic factors selected for 
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examination as moderators also represented a delimitation. The use of other demographic 
factors, such as household income, may have resulted in different findings. 
Significance, Summary, and Conclusions 
Findings from the study may have an impact for positive social change by 
informing health care providers and administrators regarding a correlation, if any, 
between health insurance payers and readmission rates. Healthcare providers and leaders 
can create programs to ensure all patients with a primary or secondary diagnosis of 
diabetes, receive appropriate care and education to reduce readmissions, improve health 
outcomes, and improve quality of life for this patient population, and result in significant 
financial savings.  
The study may also inform government policymakers with analytical data needed 
to amend the guidelines for the Hospital Readmissions Reduction Program (HRRP) 
(Krinsky et al., 2017). The study may inform hospital administrators regarding 
readmissions and diabetics to align their organization with healthcare reform guidelines 
associated Medicare spending and the HRRP. The impact of this alignment may improve 
care transitions between patients and healthcare organizations. The study results may also 
lead to improved outcomes for patients to further social good, by relieving the patient of 
the burden of returning to the hospital, which can also result in a burden relief to the 
taxpayers because of the high costs of readmissions. 
Summary 
 A review of the literature on hospital readmission among patients with diabetes 
has revealed the lack of distinction between planned and unplanned readmissions 
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(Drincic et al., 2017) and mixed findings regarding the influence of insurance payer 
status on readmissions among patients with T2DM. The researcher of this study sought to 
provide evidence to fill a gap in the literature regarding the correlation, if any, between 
readmission rates and insurance payer status among patients with T2DM. A review of 
existing research on readmission rates revealed that patients with diabetes have higher 
readmission rates than those without diabetes; yet limited information exists on efforts to 
reduce readmissions among these patients (Drincic et al., 2017). Lawmakers have 
suggested that healthcare organizations implement strategies to reduce readmissions to 
lower cost (Drincic et al., 2017). The strategies focus on identifying risk factors that may 
be associated with readmissions such as underlying comorbidities, age, the severity of 
illness, previous hospitalization and low socioeconomic status (Drincic et al., 2017). 
Applying general interventions across patient populations is cost-prohibitive. It is 
important to identify patients at the greatest risk of 30-day readmission in order to more 
efficiently utilize resources.   
An examination of the relationship between insurance payer status and 30-day 
readmission rates among T2DM patients may provide leaders with information needed to 
target appropriate interventions and reduce readmission rates. In addition, because 
readmission rates may be the result of differences in patient characteristics (Basu et al., 
2018; Carey & Lin, 2015; Singh et al., 2014), it is also important to understand how 
patients’ demographic characteristics may moderate the relationships between insurance 
payer status and readmission rates. The study addressed these important gaps in the 
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existing literature with the aim of developing findings that may be used to reduce 
readmission among patients with T2DM 
 In Section 1, I presented an introduction to the investigation and an overview of 
the literature associated with readmission rates among patients with T2DM. The next 
section presents methodological details of the study. Discussions about the study design, 




Section 2: Research Design and Data Collection 
Introduction 
The purpose of this quantitative, correlational study was to use secondary data to 
examine the relationship between primary payer status (Medicare, Medicaid, uninsured, 
or private insurance) and hospital readmission rates among individuals whose primary or 
secondary reason for admission was T2DM. In addition, I analyzed whether 
sociodemographic factors (age, gender, and income) moderate the relationship between 
primary payer status (Medicare, Medicaid, uninsured, or private insurance) and hospital 
readmission rates among individuals whose primary or secondary reason for admission 
was T2DM. In Section 2, I will detail the research design and rationale and methodology. 
In the section, I will discuss the target population, sampling design, instrumentation, and 
data analysis plan. I also discuss issues of validity and the ethical procedures used in 
working with study data. 
Research Design and Rationale 
The research method applied to assess the hypotheses was a quantitative 
multivariate analysis and the Donabedian framework. Logistic regression analysis testing 
helped to determine if there was a direct relationship between the readmission rate and 
insurance payer status for patients with T2DM as a primary or secondary diagnosis and 
30- day readmission rates. It was also helpful in determining whether a relationship 
existed when controlling for age, gender, and income. I performed a quantitative analysis 
to verify the data in the Statistical Package for the Social Sciences (SPSS). I reviewed 
multiple studies that had similar and consistent data when controlling for covariates 
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similar to the ones used in the study. The research design allowed me to measure data 
from the target population and quantified the prevalence of multiple characteristics within 
the sample population. I used the quantitative research method to determine patterns in 
payer status and 30-day readmission rates for patients nationally with T2DM.  
Methodology 
I analyzed the 2015 NRD of the HCUP using logistic regression to establish a 
relationship between the variables. To verify the data, I conducted a quantitative analysis 
using SPSS. To obtain secondary data from HCUP NRD, I completed a mandatory data 
use agreement course that included discussion of the key elements of using secondary 
data from the HCUP website. A certificate code was then issued to access the secondary 
data set electronically; the code provided authorization to use the data for research 
concentrated in the United States.   
Population 
The focus of this research was on individuals who are medically diagnosed with 
T2DM nationally. The inclusion of all patients with T2DM nationally was a requirement 
to assess the hypothesis and determine if there was a correlation between 30-day 
readmission rates and insurance payer status and between 30-day readmission rates and 
sociodemographic variables for patients with T2DM. I excluded patients who were not 
medically diagnosed with T2DM from the research study. I did not exclude participants 
based on their gender, ethnicity/ race, age, physical disability, or preexisting 
comorbidities; rather, I used the covariates to further determine additional factors that 




I used a quantitative correlational design to examine the relationship between 
insurance primary payer status (Medicare, Medicaid, uninsured, or private insurance) and 
hospital readmission rates among individuals whose primary or secondary reason for 
admission was T2DM. I also examined sociodemographic variables, insurance payer 
status, and 30-day readmission rate for patients with T2DM. A correlational research 
design allows for the measurement of a relationship between two variables without the 
researcher controlling either of them (Creswell, 2009). A correlational design was the 
most appropriate method to examine the relationship between insurance payer status and 
30-day readmission rates for patients with T2DM. 
I used a secondary data set in the research study acquired from the HCUP NRD 
for the time period of 2013 to 2015. HCUP-NRD is the Nationwide Readmission 
Database and software tools developed for the HCUP (HCUP, 2015). The NRD includes 
inpatient discharge records form community hospitals in the United States. I used the 
HCUP-NRD to look at the 30-day readmission rate for patients nationally whose primary 
or secondary reason for admission was T2DM. I used insurance payer type while 
simultaneously controlling for covariates categorized from the secondary data set.  
Data analysis. I analyzed the secondary data by using IBM SPSS Statistics v. 
23.0 (2016). The statistical analysis consisted of conducting a descriptive analysis, a two-
way test of association, followed by multivariate logistic regression to address RQ1 and 
logistic regression to address RQ2. Categorical variables were investigated to determine 
the percentage of male and female subjects and to define by race/ethnicity in each 
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category. Additional analysis assisted with categorizing the number of subjects by 
medical condition and year. The mean, mode, and standard deviation were calculated per 
category to exhibit variations per year. The research analyses assisted in establishing a 
pattern of 30-day readmission rates for patients nationally with T2DM and determining 
insurance payer status and 30-day readmission rates for patients with T2DM nationally. 
The covariates were analyzed to determine if there was a pattern associated with 30-day 
readmission rates, sociodemographic variables, and insurance payer status for T2DM 
patients nationally.   
Power analysis. I completed a power analysis using IBM SPSS Statistics v. 23.0 
(2016) with .80 power and alpha of < .05 to determine the sample size needed for each 
RQ. The power analysis calculation sample size revealed a minimum sample size of 398 
for RQ1 with power .80 and alpha < .05. This sample size needed to be significant to 
determine if there was a correlation between insurance primary payer status (Medicare, 
Medicaid, uninsured, or private insurance) and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally.  
The power analysis for RQ2 for .80 power and an alpha < .0 also revealed a 
minimum required sample size of 398. This sample size needed to be significant to 
determine whether sociodemographic factors such as age, gender, and income moderate 
the relationship between insurance primary payer status (Medicare, Medicaid, uninsured, 
or private insurance) and 30-day readmission rates among individuals whose primary or 
secondary reason for admission was T2DM nationally. 
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Data Analysis Plan 
 I used the HCUP NRD for 2013 to 2015 for the study. To analyze the data, I 
performed logistic regression using SPSS. Logistic regression is the multivariate 
extension of a bivariate chi-square analysis (Sperandei, 2014). Logistic regression allows 
the researcher to control for various demographic, analytical, clinical, and potentially 
confounding factors that affect the relationship between a primary predictor variable and 
a dichotomous categorical outcome variable (Sperandei, 2014). Logistic regression 
generates adjusted odds ratios with 95% confidence intervals (Sperandei, 2014). Once the 
calculations have been received, the logistic regression analysis will assist in determining 
a null or alternative hypothesis. 
The dependent variable was the 30-day hospital readmission rate and was 
analyzed in conjunction will the independent variables of insurance payer status 
(Medicare, Medicaid, uninsured or private insurance). The covariates within the research 
were comprised of age, gender, income, and timeframe in which services rendered 
ethnicity/race, and comorbidities. The location of the research was nationally, and the 
ethnicity consisted of Non-Hispanic/White, Asian/Pacific Islander, Black/African-
American, Hispanic, and Native American/Alaska Native. The timeframe for the research 
included three consecutive years of data to exhibit a current study aimed at exploring the 
gap in literature and current and past findings pertaining to the dependent and 
independent variables. The secondary data set was analyzed to address the following 
research study questions and corresponding hypotheses: 
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RQ1. What is the relationship, if any, between primary payer status Medicare, 
Medicaid, uninsured, or private insurance and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally? 
H01. No statistically significant relationship exists between primary payer status 
Medicare, Medicaid, uninsured, or private insurance and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally.  
HA1. A statistically significant relationship exists between primary payer status 
Medicare, Medicaid, uninsured, or private insurance and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally. 
RQ2. Do sociodemographic factors like age, gender, income moderate the 
relationship between primary payer status like Medicare, Medicaid, uninsured, or private 
insurance and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally? 
H02. Sociodemographic factors like age, gender, income do not moderate the 
relationship between primary payer status like Medicare, Medicaid, uninsured, or private 
insurance and hospital 30-day rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
HA2. Sociodemographic factors like age, gender, income moderate the 
relationship between primary payer status like Medicare, Medicaid, uninsured, or private 
insurance and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
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Threats to Validity 
In this quantitative study, the research identified, if there was the possibility of 
external and internal threats to validity. Internal and external validity are perceptions that 
replicate if the results of a study are trustworthy and meaningful (Anrade, 2018). Internal 
validity relates to how well a study is conducted external validity relates to how 
applicable the findings are to the real world (Anrade, 2018).  
Internal Validity 
Internal validity examines whether the manner in which a study was designed, 
conducted, and analyzed allows trustworthy answers to the RQs in the study (Anrade, 
2018). There could be numerous threats to internal validity such as, improper 
randomization, inadvertent unblinding of patients or raters, missing data. Internal validity 
is based on judgment and is not a computed statistic (Anrade, 2018). Internal validity 
examines the extent to which bias is present.  
External Validity 
External validity of the study may be affected if the study population is not a true 
representation of the target population that is eligible for the study (Anrade, 2018). 
External validity pertains to appropriate inferences or generalizations of research results 
to other populations (Rooney et al., 2016). Random sampling was chosen to assure the 
validity of the study.  
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Data Protection and Privacy 
Treatment of Data 
 The research study underwent the approval process from Walden University 
Institutional Review Board (IRB) to utilize an external secondary dataset. The Data 
Protection Act 2018 (DPA) (updated to the 1998 DPA) protects individuals from being 
exploited and their personal information from unwanted distribution (Spencer & Patel, 
2019). This update to the DPA was necessary due to the ongoing technological advances 
of social media. The data protection act ensures that Protected Health Information (PHI) 
is safeguarded. PHI includes an individual’s demographic information, such as age, date 
of birth, Social Security number, address, and telephone number (Craig, 2017). The 
Health Insurance Portability and Accountability Act (HIPAA) privacy rule requires 
healthcare providers to maintain the confidentiality of a patient’s protected health (Craig, 
2017). 
Permissions 
For this doctoral research, before data collection could begin, the IRB had to 
review and approve the methods and procedures that the researcher planned to use. To 
obtain secondary data from HCUP, a mandatory data use agreement course was 
completed that discussed the key elements of utilizing secondary from the HCUP website 
(Agency for Healthcare Research and Quality, 2019). A certificate code was then issued 
to access the secondary dataset electronically and provide authorization for utilizing data 




The protection of human subjects during research requires permission for 
academic institutions and clinical trials. All patient specific information was protected 
and underwent re-coding where necessary to uphold patient privacy during the duration 
of the research study. Approval from Walden IRB and HCUP privacy agreement use 
were obtained. The research does not present any ethical issues for the university, 
researcher, or the participants to further determine gaps in previous related literature. 
Ethical Procedures 
 In meeting the requirements of Walden’s standards, this was a Walden doctoral 
study which required the approval of the Institutional Review Board (IRB) to fulfill all 
the requirements of Walden University. As a researcher, the ethics of confidentiality and 
data security are important. To alleviate research bias, only data gathered from a public 
database was used for this study. 
Permission 
The 2015 HCUP NRD is a public database; therefore, there was not direct contact 
with participants in this study. Permission to obtain and use this data was obtained after 
completion of the HCUP Data Use Agreement Training Course. Before data collection 
can begin on a project, the IRB must review and approve the methods and procedures that 
will be used. Prior to implementation of this practice change, appropriate knowledge and 





This section presented the methodology of the quantitative study. The description 
about population, sampling, design, and rationale for data collection and analysis were 
described. Section 3 will provide the interpretation of the results of the data, results, and 




Section 3: Presentation of the Results and Findings 
Introduction 
In Section 3, I will review the data collection and statistical analysis of the 
secondary data discussed in Section 2. The objective of the research study was to 
determine whether there was a correlation between 30-day readmission rates among 
patients whose primary or secondary reason for admission was T2DM, while controlling 
for multiple covariates. I calculated and analyzed a number of descriptive and inferential 
statistics, including the frequency, standard deviation, average, percentage, mean, mode, 
sum, and differences of the participants. 
I retrieved participants from the HCUP nationwide readmissions database of the 
2015 NRD, which is an extensive, publicly available inpatient database containing data 
on over 7,000,000 hospital stays in the United States (HCUP, 2015). Logistic regression 
was the primary analysis employed for this research. The RQs and hypotheses for this 
study were, 
RQ1. What is the relationship, if any, between primary payer status (Medicare, 
Medicaid, uninsured, or private insurance) and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally? 
H01. No statistically significant relationship exists between primary payer status 
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates 




HA2. A statistically significant relationship exists between primary payer status 
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates 
among individuals whose primary or secondary reason for admission was T2DM 
nationally. 
RQ2. Do sociodemographic factors like age, gender, and income moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally? 
H02. Sociodemographic factors like age, gender, and income do not moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and hospital 30-day rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
HA2. Sociodemographic factors like age, gender, and income moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
Data Collection of Secondary Data Sets 
I filtered the available raw data of the NRD database to review the study variables 
for the doctoral study. The initial sample size for the secondary data set comprised over 
500,000 cases for 2013, 2014, and 2015. All three years were reviewed. I focused on the 
most current year of the 2015 NRD dataset, which resulted in a sample size of 41,068. 
The data set was filtered to include age, gender, income, diagnosis, and insurance payer 
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status. Participants in the data set included 41,068 patients with T2DM. The age range of 
the participants was 20 to 90 years old.  
Results 
A binary logistic regression was the analysis to test the contributions of primary 
payer status (i.e., Medicare, Medicaid, uninsured, or private insurance) in predicting the 
likelihood that respondents, with diabetes without complications, would be readmitted 
within 30 days. With the dependent variable being dichotomous, logistic regression was 
the appropriate statistical analysis because it permitted the examination of the odds of 
membership in one of the two outcome groups (i.e., under 30 days, more than 31 days). 
The χ2 omnibus test of model coefficients was used to assess whether adding the 
independent variables significantly increased the ability to predict hours per week 
worked. Additionally, I used the Nagelkerke R2 to assess the percentage of variance 
accounted for by the independent variables. Finally, the predicted probabilities of an 
event occurring were determined by examining the odds ratio. Preliminary analyses of 
the data set were conducted to observe whether the assumptions of logistic regression 
were met. 
Participants 
 Participants in the data set included 41,856 diabetes patients. The largest income 
bracket was those in the $1-$41,999 range (34.1%). A majority (53.7%) were female, and 
the largest age group was those who were 60 years of age and older (N = 30,309). Most 
participants used Medicare (68.4%). For the additional analysis, the majority of the 
54 
 
sample identified had diabetes with complications (61.7%). The frequencies are presented 




Variables Categories N % 
Income $1-41,999 14,288 34.1 
 42,000-51,999 10,382 24.8 
 52,000-67,999 9,499 22.7 
 68,000 and higher 7,072 16.9 
    
Payment status Medicare 27,906 68.4 
 Medicaid 5,419 13.3 
 Private Insurance 6,593 16.2 
 No Insurance 843 2.07 
    
Gender Male 19,397 46.3 
 Female 22,517 53.7 
    
Age brackets 20-29 741 1.77 
 30-39 1,513 3.61 
 40-49 2,986 7.12 
 50-59 6,365 15.19 
  60 and older 30,309 72.31 
 
RQ1 and its corresponding hypotheses were as follows: 
RQ1. What is the relationship, if any, between primary payer status (Medicare, 
Medicaid, uninsured, or private insurance) and 30-day readmission rates among 
individuals whose primary or secondary reason for admission was T2DM nationally? 
H01. No statistically significant relationship exists between primary payer status 
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates 
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among individuals whose primary or secondary reason for admission was T2DM 
nationally.  
HA1. A statistically significant relationship exists between primary payer status 
(Medicare, Medicaid, uninsured, or private insurance) and 30-day readmission rates 
among individuals whose primary or secondary reason for admission was T2DM 
nationally. 
First, I examined the assumptions. The multicollinearity tolerance values for the 
independent values ranged from 1.73 to 8.90, which lies between the 1-10 range; 
therefore, multicollinearity was not present (see Hair, Anderson, Tatham, & Black, 
1995). Next, an inspection of the data (see Table 1) confirmed that the ratio of cases to 
variables was adequate. Finally, the Hosmer and Lemeshow Goodness-of-Fit test was 
conducted to test the null hypothesis that the data fit the specified model, χ2(3) = 0.001, p 
= 1.00, and the test was not statistically significant; therefore, a non-statistical result 
indicated that the data indeed fit the specified model. As a result, the null hypothesis was 
retained.  
Medicare and those without insurance were significant predictors of being 
readmitted within 30 days. Those with Medicaid (95% CI: 0.76 – 0.92; p = .001) had a 
45.76% probability of being re-admitted within 30 days while those with no insurance 
(95% CI: 0.76 – 0.94; p = .002) also had a 45.76% probability of being re-admitted 
within 30 days. The overall model was statistically significant χ2(4) = 40.95, p = 0.001. 
Additionally, the four independent variables explained only 1% (Nagelkerke R2) of the 
variance for the probability of being re-admitted and correctly classified 71.8% of the 
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cases. As a result, for H01, the null hypothesis was rejected, and the alternative 







Logistic Regression Analysis of Hospital Readmission with OR, 95% CI, Wald and P Values 
(N = 41,856) 
 
  OR 95% CI Wald P 
Variables   Lower Upper     
Medicare 1.25 1.10 1.43 11.63 0.001 
Medicaid 1.16 1.01 1.33 4.22 0.040 
Private Insurance 1.05 0.92 1.21 0.51 0.474 
No Insurance 1.22 1.00 1.48 3.77 0.052 
Constant 2.22     135.90 0.001 
 
Research Question 1 
 For the first RQ, a binary logistic regression was the statistical analysis to 
examine which independent variables were significant in predicting 30-day readmission. 
Readmission analyses often consider the time between the end of one admission and the 
start on the next admission, where the number of days between the beginning of each 
entry was coded ‘0’ for readmission within 30 days or less and ‘1’ for re-entry over 31 
days. To calculate this date, the verified patient linkage (i.e., NRD-visitLink) variable 
was used.   
The NRD-visitLink variable is a data element created for the Nationwide 
Readmissions Database to track patients across hospitals in a year. For this dataset, if a 
patient had more than two rows of data, then they were readmitted. Data were transposed 
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on the patient linkage variable, and the number of days between each admission was 
calculated. The frequency of those being admitted within 30 days was 28.1% (N = 
11,884) compared to those who were not (N = 30,344). For RQ2, a hierarchal logistic 
regression was the statistical procedure to examine which demographic variables were 
significant in moderating the 30-day readmission rate.  
Research Question 2 
RQ2. Do sociodemographic factors like age, gender, and income moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally? 
H02. Sociodemographic factors like age, gender, and income do not moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and hospital 30-day rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
H12. Sociodemographic factors like age, gender, and income moderate the 
relationship between primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. 
A hierarchal binary logistic regression was the statistical analysis to test the 
contributions of primary payer status (i.e., Medicare, Medicaid, uninsured, private 
insurance) along with the moderating variables of age, gender, income in predicting the 
likelihood that respondents, with diabetes without complications, would be readmitted 
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within 30 days. Age was treated as a continuous variable, while gender and income were 
dummy coded. First, the assumptions were examined. The multicollinearity tolerance 
values for the independent values ranged from 1.01 to 9.35, which lies between the 1-10 
range; therefore, multicollinearity is not present (Hair et al., 1995). 
Next, an inspection of the data (See Table 1), confirmed that the ratio of cases to 
variables was adequate. The Hosmer and Lemeshow Goodness-of-Fit test was conducted 
to test the null hypothesis that the data fit the specified models for model 1, χ2(8) = 
12.681, p = .123, and for model 2 χ2(8) = 6.573, p = .583. Both tests for models 1 and 2 
were not statistically significant; therefore, a non-statistical result indicated that the data 
does indeed fit the specified model. As a result, the null hypothesis was retained.  
The first model (i.e., step one), which only considered the socioeconomic 
variables, was significant χ2(5) = 33.18, p = .001. Both gender and age were significant 
predictors of being readmitted within 30 days. Females had a .91 (95% CI: 0.87 – 0.95) 
times higher odds of being readmitted within 30 days, compared to males. Additionally, 
as age increased by one unit, the odds increased by 1.00 (95% CI: 1.00 – 1.00). Overall, 
model one correctly classified 71.9% of the cases. The second model, which took the 
socioeconomic variables and the payment methods, was also significant χ2(9) = 64.26 p = 
.001. 
In this model, gender was the only socioeconomic variable to moderate readmission 
status. Females had a .91 (95% CI: 0.87 – 0.95) times higher odds of being 
readmitted within 30 days, compared to males. Additionally, Medicare was a 
significant predictor of being readmitted where those with Medicare were .80 (95% 
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CI: 0.87 – 0.95) times higher odds of being readmitted. Model two correctly 
classified 71.9% of the cases and explained less than 2% of the variance. As a 
result, for H02, the null hypothesis was rejected, and the alternative hypothesis was 
accepted. The results are presented in Table 4.   
Table 4 
 
Hierarchical Logistic Regression Analysis of Hospital Readmission with OR, 95% 
CI, Wald, and P Values (N = 41,856) 
 OR   95% CI Wald P 
Variable      Lower Upper     
  Model 1     
Female 1.11  1.07 1.16 23.72 0.001 
Ages 20-29 0.91  0.77 1.07 1.32 0.250 
Ages 30-39 0.74  0.67 0.83 27.36 0.001 
Ages 40-49 0.99  0.91 1.08 0.06 0.813 
Ages 50-59 1.00  0.94 1.06 0.03 0.868 
Income 1 - 41,999 1.04  0.98 1.11 1.71 0.191 
Income 42,000 - 51,999 1.04  0.97 1.11 1.26 0.261 
Income 52,000 - 67,999 0.97  0.90 1.03 0.99 0.320 
Constant* 2.41       907.71 0.001 
                Model 2 
    
Female 1.11  1.06 1.16 20.72 0.001 
Ages 20-29 1.00  0.84 1.18 0.00 0.967 
Ages 30-39 0.81  0.72 0.91 12.45 0.001 
Ages 40-49 1.07  0.98 1.17 2.00 0.157 
Ages 50-59 1.08  1.01 1.15 4.37 0.037 
Income 1 - 41,999 1.04  0.97 1.10 1.14 0.287 
Income 42,000 - 51,999 1.04  0.97 1.11 0.98 0.323 
Income 52,000 - 67,999 0.97  0.90 1.04 0.93 0.336 
Medicare 1.25  1.09 1.43 10.57 0.001 
Medicaid 1.13  0.98 1.30 2.59 0.107 
Private Insurance 1.05  0.91 1.20 0.40 0.528 
No Insurance 1.19  0.98 1.46 3.02 0.083 
Constant* 1.99       91.50 0.001 
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The reference group contains male participants in the 60 and over age range and those 
with an income of $68,000 more. 
      
 
Additional Analysis 
For both RQs, I only analyzed patients who had diabetes without complications; 
however, I was interested in whether there was a significant difference between those 
with (N = 62,627) and without complications (N = 41,184) regarding readmitted status. 
Those who had diabetes with without complications were coded as ‘0’ and those with 
diabetes with complications were coded as ‘1.’ The logistic regression results revealed a 
significant relationship χ2(1) = 200.07, p = 0.001 and correctly identified 74.2% of the 
cases. Those with complications (95% CI: 1.19 – 1.26; p = .001) had a 75.7% predicted 
probability of being re-admitted within 30 days while those who did not have 
complications had only a 71.83% probability of being admitted within 30 days. This 




Logistic Regression Analysis of Hospital Readmission with OR, 95% CI, Wald, 
and P values (N = 103,811) 
  OR   95% CI Wald p 
Variable      Lower Upper     
With Complications 1.22  1.19 1.26 201.14 0.001 





In this section I used a descriptive analysis to summarize the variables and 
measurements within the research study, utilizing a quantitative analysis. The Hosmer 
and Lemeshow Goodness-of-Fit test was conducted to test the null hypothesis to ensure 
that the data fit the specified models for both RQs. The objective of the binary logistic 
regression was to establish which variables correlated to the 30-day readmission rate for 
patients with diabetes and determine the odds ratio, 95% confidence interval, and the 
statistical significance of each variable.  
Participants in the data set included 41,068 diabetes patients. The largest income 
bracket was those in the $1 - $41,999 range (34.1%). A majority (53.8%) were female, 
and the age range of all participants was grouped between 20-29, 30-39, 40-49, 50-59, 
and 60- 90 years old (M = 67.26, SD = 15.68). Most participants used Medicare (67.9%). 
For the additional analysis, the majority of the sample identified had diabetes with 
complications (62.1%).  
The null hypothesis for RQ1 was retained. No statistically significant relationship 
existed between insurance primary payer status (Medicare, Medicaid, uninsured, or 
private insurance) and 30-day readmission rates among individuals whose primary or 
secondary reason for admission was T2DM nationally. It was observed that possession of 
Medicare and lack of insurance was significant predictors of being readmitted within 30 
days.  
The null hypothesis was also retained for RQ2. Sociodemographic factors like 
age, gender, and income did not moderate the relationship between insurance primary 
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payer status like Medicare, Medicaid, uninsured, or private insurance) and 30-day 
hospital readmission rates among individuals whose primary or secondary reason for 
admission was T2DM nationally. When controlling for gender, females had a .91 (95% 
CI: 0.87 – 0.95) times higher odds of being readmitted within 30 days, compared to 
males. 
The evidence collected and the data analyzed during this quality improvement 
project added benefit to the advancement of research in this area. In the next section I 
will expand on the findings, implications, and recommendations relating to the objective 
of the research study were to determine whether there was a correlation between 30-day 
readmission rates among patients whose primary or secondary reason for admission was 





Section 4: Application to Professional Practice and Implications for Social Change 
Introduction 
In this chapter, I will further discuss the study findings and present 
recommendations formulated as an outcome of the research study. Hospital readmission 
within 30 days of discharge is a significant topic of health care reform in the United 
States. Reforms can include implementing protocols prior to discharge that may prevent 
possible readmissions and possibly reduce the cost to both the facility and the patient. A 
facility’s 30-day readmission rate encompasses all unplanned readmissions that occur 
within 30 days of discharge regardless of the cause (CMS, 2013). The risk index includes 
patients who are readmitted to the same hospital or another acute care hospital for any 
reason regardless of their primary diagnosis (CMS, 2013). The measures do not include 
planned readmissions. Currently, CMS measures hospital performance in the HRRP by 
calculating ERRs for each of the program measures. 
 The quantitative cross-sectional study looked at  patients who experienced 30-
day readmissions to hospitals nationally in 2015 for a primary or secondary reason of 
T2DM. Logistic regression was used to analyze data to find a correlation between the 
independent variables of primary payer status (Medicare, Medicaid, uninsured, or private 
insurance) and the dependent variable of hospital readmission rate. Results of logistic 
regression analysis showed that possession of Medicare and lack of insurance were 
significant predictors of being readmitted within 30 days. Women had higher odds of 
being readmitted within 30 days compared to men. 
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Interpretation of the Findings 
Findings from this quantitative research study revealed that the largest income 
bracket was $1-$41,999 range (34.1%), that majority of the participants (53.8%) were 
female, and that the age range of all participants was between 20-90 years old (M = 
67.26, SD = 15.68). Most participants had Medicare (67.9%). An additional analysis 
revealed that much of the sample identified had diabetes with complications (62.1%). The 
data analysis showed there was no statistically significant relationship between primary 
payer status and 30-day readmission rates among individuals whose primary or secondary 
reason for admission was T2DM nationally. Participants with Medicare and those without 
insurance were significant predictors of being readmitted within 30 days. 
Sociodemographic factors like age, gender, and income do not moderate the relationship 
between primary payer status and 30-day hospital readmission rates among individuals 
whose primary or secondary reason for admission was T2DM nationally. Women had 
higher odds of being readmitted within 30 days compared to men. These findings implied 
that the control health systems have achieved substantial improvements in readmission 
rates among patients with T2DM is limited. More work is needed to distinguish the 
expected impact of intrinsic hospital traits versus quality improvement strategy 
implementation particularly when considering how costly implementation of strategies 
can be in a resource-limited environment (Bennett, et al., 2020). 
Limitations of the Study 
This doctoral research study was subject to some limitations. One very significant 
limitation was the use of the HCUP NRD (2015), which is a very large public data set. 
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When using large data sets, researchers often face issues with accuracy (Smith, et al., 
2011).  The source of the data input for the NRD came from a host of state-level 
affiliates. Even though the NRD strives for consistency of its affiliates, the consistency of 
the submission often comes with challenges such lack of control over variables and data. 
Large sample sizes may introduce bias, like errors in measurements, errors in sampling, 
and systematic omission of essential information (Kaplan, Chambers, & Glasgow, 2014).  
Current literature also identifies the limits of administrative data (Harron, et al., 2017). It 
is important that the data collection and the data analysis are consistent and/or in 
alignment when using large data sets. This is not always the case. The difficulty in the 
coding process and the expertise of the coders can also adversely affect the results of the 
study. The impacts cannot be regulated or measured by the researcher, which is also a 
limitation. Regardless of these limitations, I believe that this research should be deemed 
original and indicative of the need for more meaningful research to be performed. 
Recommendations 
Patient education and care transitions are important in the reduction rate of 30-day 
readmission rate for patients with T2DM. The present study’s time frame (FY2015) was 
3 years after implementation of the HRRP in (2012), so the present results should be at 
least somewhat indicative and representative of projected outcomes of the HRRP, after 
adequate implementations have taken place. A mixed-methods study on comorbidities 
should also be conducted to see what role or if any percentage of underlying health 
conditions are involved in the 30-day readmission rate of patients with T2DM. Hospital 
administrators should conduct both internal and external surveys. The survey results may 
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help connect hospital performance measures with the 30-day readmission rate. The prime 
objective of administrators and personnel within hospitals is to provide impeccable 
service to patients (Loria, 2018). Findings suggest that administrators and personnel 
should continue their efforts to improve services. Internal surveying could also help 
shape the climate and effectiveness of the working environment. 
Implications for Professional Practice and Social Change 
Methodological, Theoretical, and Empirical Implications 
I used a quantitative design as this was the most appropriate research design for 
studying the 30-day readmission rate for patients with T2DM and insurance payer status 
and sociodemographic status of patients with T2DM. A statistical analysis was performed 
for the HCUP NRD (2015). Income, insurance payer status, age, and gender were the 
variables used to collect data. These variables were properly used for testing as they met 
the qualifications and conditions for statistical analysis as it related to the research (see 
Section 3). I did not find a significant predictor model. The results may therefore offer 
limited applications for professional practice.  
The conceptual framework used in this quantitative research study was the 
Donabedian framework (Ayanian & Markel, 2016). Healthcare facilities may use the 
model to exam health services and evaluate the quality of healthcare (Ayanian & Markel, 
2016). A hospital administrator can utilize the concepts of the Donabedian model to 
develop strategies and programs that may help the organization and the community 
reduce the rate of 30-day readmissions for patients with T2DM.  
67 
 
Positive Social Change 
Evidence from this research may create positive changes by informing 
administrators, healthcare professionals, and hospital leaders regarding the importance of 
providing resources for patients with T2DM. Findings from the study may specifically 
lead to positive social change by informing health care providers and administrators 
regarding whether there is a correlation between health insurance payers and readmission 
rates of patients with T2DM. Healthcare providers and leaders can create programs to 
ensure that all patients with a primary or secondary diagnosis of diabetes receive 
appropriate care and education to reduce readmissions, improve health outcomes, and 
improve quality of life for this patient population, which may result in significant 
financial savings for patients and healthcare facilities.  
Administrators can potentially use the findings of the study to decrease hospital 
readmission rates of patients with T2DM by providing thorough after-care instruction for 
the lay person. According to experts, providers should encourage follow-up care with 
primary care physician at least a week after discharge for T2DM treatment (Loria, 2018). 
The hospital and the patient must work as a team to reduce hospital readmissions and 
costs to both the hospital and the patient (Loria, 2018). 
Conclusion 
Thirty-day hospital readmission rates are an important performance indicator for 
hospitals in the United States (Gerhardt et al., 2012). The government put policies such as 
HRRP in place to encourage hospitals to find strategies to reduce excessive readmission 
rates. At the time of this study, these policies have been somewhat effective in achieving 
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their specified goal (Ferro, et al., 2019). Current regulations indicate that the hospital is 
the primary stakeholder in the healthcare equation in decreasing 30-day readmission 
rates. However, this study showed that hospitals can affect only a small proportion of 
readmission rates. The current policy does not take into consideration many of the 
readmission-driving factors that are not modifiable by the hospital in its readmission rate 
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